Page 121 - Clinical Immunology_ Principles and Practice ( PDFDrive )
P. 121

CHaPter 6  Overview of T-Cell Recognition              105


           MIR2 and EBV BILF1). Together, these and other mechanisms   compartments accessed later during biosynthesis of the MHC
           prevent detection by CD4 and CD8 T cells and the ensuing   protein.  Within each of these compartments resides a set of
           protective immune response.                            proteins that participate in and direct peptide loading. Both
                                                                  class I and class II molecules acquire peptides inefficiently, and
           Tumor Escape From Immune Surveillance                  accordingly both require critical protein cofactors that prepare
           Tumor progression is often associated with alterations in the   the MHC protein to capture peptide. The presentation events
                                                        46
           expression and/or function of the MHC class I molecules.  Loss   are also similar in that they allow only a subset of the potential
           of DNA binding factors needed for promoter activation can lead   self or pathogens peptides to be presented. Peptide editing of
           to altered class I transcription. Loss of β2m gene expression can   the repertoire of peptides presented by MHC proteins is primarily
           lead to a global defect in class I protein expression at the cell   based on the ability to stably interact with the MHC protein.
           surface. Downregulation of the components of the constitutive
           and immune-proteasome have been identified in a number of    on tHe HorIZon
           cancers. Low levels of TAP transporter components and the ER
           aminopeptides (ERAAP) have been seen in others. Loss or   •  New means to regulate class II antigen presentation could come from
           diminution of class I presentation of peptides is often associated   a better understanding of the mechanisms by which HLA-DO regulates
                                                                     HLA-DM or from the elucidation of new mechanisms by which
           with disease progression, metastasis, and a detrimental clinical   viral or bacterial products antagonize the MHC class II presentation
           outcome in part as a result of evasion of immune detection and   pathway.
           impaired elimination of the transformed cells.          •  New means to regulate class I antigen presentation could come from
                                                                     a better understanding of the mechanisms used to regulate proteasome
           Potential Role of “Peptide Editing” of Presented          generated cytosolic peptides and their transport by TAP (for transporter
           Peptides on Self Tolerance and Autoimmunity               associated with antigen processing) to MHC class I molecules and
                                                                     from a better understanding of cross-presentation.
           HLA-DM edits the repertoire of peptides presented by HLA-class   •  A better understanding of the similarities and differences in antigen
           II molecules at the cell surface. These are the only peptides that   presentation by the various APC subsets could lead to new vaccination
           are available to interact with circulating CD4 T cells. Tapasin   methods.
           appears  to  have  a  similar  function  for  MHC  class  I  peptide   •  A better understanding of the role of cryptic peptides in CD8 T-cell
           binding, enriching for presentation of peptides that bind with   selection events could lead to the manipulation of CD8 T-cell responses
           high affinity with the MHC class I molecule. This selective peptide   to tumors, viruses, and autoantigens.
           display by MHC molecules has important implications for self
           tolerance and autoimmunity. Tolerance to self arises as a con-  Because of MHC polymorphism, the peptides selected for
           sequence of deletion of developing T cells whose TCR recognizes   protection, self tolerance, and autoimmunity will vary from one
           self peptides presented by host MHC molecules within the thymus   individual to the next. Many pathogens have developed specific
           (Chapter 8). This is termed central tolerance. Accordingly, central   proteins that degrade or interfere with the essential functions
           tolerance can only be operative if a self peptide is displayed at   of the protein cofactors that regulate MHC-restricted antigen
           the cell surface of APCs in the thymus. The bone marrow-derived   presentation. These viral evasions strategies allow the infected
           MHC class II and MHC class I positive APCs responsible for   host cell to avoid immune recognition and destruction by CD8
           deletion of self-reactive cells express the HLA-DM and tapasin   and CD4 T cells. Interference with antigen presentation also
           proteins and thus will only express peptides that bind with high   leads to the escape of host cells from tumor-specific surveillance
           affinity to MHC class II molecules. Therefore the host is selectively   and allow progressive growth and metastases.
           tolerant only to host peptides that survive this intracellular editing   We now understand many of the key players in MHC-restricted
           during biosynthesis of the MHC proteins. Self peptides that are   presentation of antigen to CD4 and CD8 T cells. In the future
           removed from MHC molecules during endosomal DM editing   this understanding will be used for vaccine design strategies,
           or ER-associated tapasin editing are essentially invisible to   and in personalized medicine aimed at enhancing immunosurveil-
           developing T cells. T cells that have escaped deletion in the thymus   lance and protection mediated by the adaptive immune response.
           will seed the peripheral pool of circulating T cells. The mature
           CD4 and CD8 T cell repertoire therefore maintains reactivity   ACKNOWLEDGEMENT
           to some self peptides. Events in the periphery that modify
           presentation of this subset of lower affinity peptides for MHC   With the permission of authors J. Rodgers and R. Rich, the section
           molecules will thus allow their display at the cell surface potentially   of this chapter that discusses the nature of antigens was repro-
           leading to recognition by host CD8 or CD4 T cells and thus   duced, with modification, from Chapter 6 of the 4th edition of
           initiation or propagation of autoreactivity.           Clinical Immunology: Principles and Practices.

           SUMMARY                                                Please check your eBook at https://expertconsult.inkling.com/
                                                                  for self-assessment questions. See inside cover for registration
           The intracellular events involved in MHC class I and class II   details.
           restricted antigen presentation have many commonalities,
           although they are different in the details. Both can be considered   REFERENCES
           three-chain proteins, where the bound peptide is the third chain.
           Binding of peptide is needed for conformational integrity of the   1.  Silverstein AM. Paul Ehrlich’s Receptor Immunology: The Magnificent
                                                                    Obsession. New York: Academic Press; 2001.
           protein, and accordingly, self or antigenic peptides must be present   2.  Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate
           throughout biosynthesis. Both have a primary site of peptide   receptors in infection and immunity. Immunity 2011;34:637–50.
           acquisition: For class I molecules, it is early in biosynthesis    3.  Desai SN, Clemens JD. An overview of cholera vaccines and their public
           within the ER, and for class II, it is within acidic endosomal   health implications. Curr Opin Pediatr 2012;24:85–91.
   116   117   118   119   120   121   122   123   124   125   126